Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$230M |
| 2 |
Johnson & Johnson
JNJ
|
+$205M |
| 3 |
Bank of America
BAC
|
+$163M |
| 4 |
Costco
COST
|
+$162M |
| 5 |
GSK
GSK
|
+$131M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$396M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$219M |
| 3 |
GE Aerospace
GE
|
+$156M |
| 4 |
Walt Disney
DIS
|
+$154M |
| 5 |
Amazon
AMZN
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.36% |
| 2 | Healthcare | 13.06% |
| 3 | Consumer Discretionary | 12.03% |
| 4 | Consumer Staples | 11.17% |
| 5 | Industrials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ORBC
1701
DELISTED
ORBCOMM, Inc.
ORBC
| $2.22M | 0.01% |
350,600
+42,700
| +14% | +$257K |
|
|
ROIC
1702
DELISTED
Retail Opportunity Investments Corp.
ROIC
| $2.22M | 0.01% |
150,900
-60,600
| -29% | -$880K |
|
|
TC
1703
DELISTED
Thompson Creek Metals Company Inc. Ordinary Shares (Canada)
TC
| $2.21M | 0.01% |
1,014,963
+35,863
| +4% | +$102K |
|
1704
Compass Diversified
CODI
$752M
| $2.2M | 0.01% |
112,131
+84,808
| +310% | +$1.58M |
|
1705
Entravision Communication
EVC
$1.02B
| $2.2M | 0.01% |
361,300
-386,000
| -52% | -$2.39M |
|
1706
Climb Global Solutions
CLMB
$528M
| $2.2M | 0.01% |
649,600
+1,600
| +0.2% | +$5.27K |
|
|
1707
Bristol-Myers Squibb
BMY
$129B
| $2.19M | 0.01% |
41,200
-4,297,700
| -99% | -$219M |
|
|
MRH
1708
DELISTED
MONTPELIER RE HOLDINGS LTD
MRH
| $2.19M | 0.01% |
75,100
-53,700
| -42% | -$1.5M |
|
1709
Cytokinetics
CYTK
$10.6B
| $2.18M | 0.01% |
+335,267
| New | +$2.2M |
|
|
STKL
1710
DELISTED
SunOpta
STKL
| $2.17M | 0.01% |
217,300
+90,270
| +71% | +$870K |
|
1711
Prudential Financial
PRU
$42.6B
| $2.17M | 0.01% |
+23,500
| New | +$2.01M |
|
1712
Center Bancorp
CNOB
$1.65B
| $2.16M | 0.01% |
115,236
+13,400
| +13% | +$216K |
|
|
GTIV
1713
DELISTED
GENTIVA HEALTH SERVICES INC
GTIV
| $2.16M | 0.01% |
174,216
+23,700
| +16% | +$285K |
|
1714
Vicor
VICR
$8.33B
| $2.14M | 0.01% |
159,500
-31,600
| -17% | -$315K |
|
|
ZEP
1715
DELISTED
ZEP INC COM STK (DE)
ZEP
| $2.14M | 0.01% |
+117,700
| New | +$2.21M |
|
1716
Snap-on
SNA
$21.5B
| $2.14M | 0.01% |
+19,500
| New | +$2.02M |
|
|
URS
1717
DELISTED
URS CORP
URS
| $2.13M | 0.01% |
40,266
-48,700
| -55% | -$2.56M |
|
|
JOBS
1718
DELISTED
51job Inc
JOBS
| $2.13M | 0.01% |
54,600
-17,600
| -24% | -$656K |
|
|
PACR
1719
DELISTED
PACER INTL INC TENN
PACR
| $2.13M | 0.01% |
257,400
+139,000
| +117% | +$1.08M |
|
|
ABMD
1720
DELISTED
Abiomed Inc
ABMD
| $2.12M | 0.01% |
79,323
-181,200
| -70% | -$4.48M |
|
|
COWN
1721
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $2.12M | 0.01% |
135,553
+67,525
| +99% | +$1.03M |
|
|
BFS
1722
Saul Centers
BFS
$858M
| $2.12M | 0.01% |
44,400
+13,200
| +42% | +$632K |
|
|
BCOV
1723
DELISTED
Brightcove, Inc.
BCOV
| $2.12M | 0.01% |
149,560
+132,160
| +760% | +$1.85M |
|
|
B
1724
DELISTED
Barnes Group Inc.
B
| $2.11M | 0.01% |
55,126
-147,574
| -73% | -$5.39M |
|
1725
La-Z-Boy
LZB
$1.64B
| $2.11M | 0.01% |
68,100
-85,700
| -56% | -$2.22M |
|
Similar funds
Renaissance Technologies's Q4 2013 Portfolio in Review
As of Q4 2013, Renaissance Technologies held 3,281 positions worth $41.8B, up 1.3% from $41.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies withdrew a net $2.31B in Q4 2013, closing 464 positions and reducing 983 holdings. Its most notable exit was GE Aerospace, an estimated $156M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Pfizer worth $230M.
- Renaissance Technologies's largest Q4 2013 buy was Pfizer: 7,904,832 shares worth $230M.
- Renaissance Technologies added most to Johnson & Johnson in Q4 2013, an estimated $205M increase.
- Renaissance Technologies's biggest Q4 2013 reduction was IBM, cutting an estimated $396M.
- Renaissance Technologies fully exited GE Aerospace in Q4 2013, selling an estimated $156M.
- Renaissance Technologies's ten largest holdings make up 11% of its $41.8B portfolio in Q4 2013.
- Renaissance Technologies opened 498 new positions and closed 464 in Q4 2013.
- Renaissance Technologies's portfolio value rose 1.3% quarter-over-quarter to $41.8B.
Based on Renaissance Technologies's 13F filing for Q4 2013, filed 14 Feb 2014.